SCLERO.ORG
Search
SCLERO.ORG is retiring 4-24-2021. Thank you for the memories! You'll still find us in the Wayback Machine, and we'll carry your stories in our hearts forever.

Research on Diabetes

Janey WillisHello, I am Janey Willis, ISN Guide to Diabetes. Type 1 Diabetes is an autoimmune disease, and Type 2 Diabetes is caused by risk factors such as lifestyle, ethnicity, age, and pregnancy. The majority of diabetics have Type 2. See Disclaimer.

Clinical Trials for Diabetes Research on Diabetes

Clinical Trials for Diabetes

Research on Diabetes KaleidoscopeClinical trials give patients the opportunity to try treatments that are still in development. Ask your diabetic specialist if there are any clinical trials suitable for you. (Also see Autoimmune Diseases and Overview of Diabetes)

Research on Diabetes

Soluble Antigen Arrays (SAgAs) Efficiently Deliver Peptides and Arrest Spontaneous Autoimmune Diabetes. SAgAs offer a novel and promising Antigen-specific immunotherapy platform superior to soluble peptides in inducing tolerance while mitigating risks of anaphylaxis for the treatment of T1D. PubMed, Diabetes, 2021 Jan 19;db200845.

Distinct Phenotypes of Islet Antigen-specific CD4+ T Cells Among the Three Subtypes of Type 1 Diabetes. The phenotypes of islet antigen-specific CD4+ T cells differed among the three T1D subtypes. PubMed, J Clin Endocrinol Metab, 07/11/2020.

Polyglandular autoimmunity in autoimmune thyroid disease (AITD) behaves differently from polyglandular autoimmunity in type 1 diabetes. AITD shows clustering of gastric autoimmunity with celiac and adrenal autoimmunity, which is consistent with the proposed entity of the autoimmune polyglandular syndrome type 2. J. Wiebolt. (Also see Thyroid Disease)

Go to Support for Diabetes
 

SCLERO.ORG was the world's leading nonprofit for trustworthy research, support, education and awareness for scleroderma and related illnesses from 1998 to 2021. It was a grassroots movement from the original Scleroderma from A to Z web site, which was founded by Shelley Ensz. We were a 501(c)(3) U.S.-based public charitable foundation. We closed this web site and our nonprofit agency in April 2021.

International Scleroderma Network (ISN)